Please confirm you are human (Sign Up for free to never see this)
← Back to Search
The Clonal Evolution Of Tumor Cell Populations.
Published 1976 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.
This paper references
The chromosomes in ontogeny and oncogeny.
T. Hauschka (1961)
Agricultural Research System
N. Wade (1976)
Suppression of malignancy in human cells
E. Stanbridge (1976)
Neoplasia: a disease of cell differentiation.
C. Markert (1968)
Reversible appearance of a specific chromosome which suppresses malignancy
S. Codish (1974)
Tumor Etiology and Chromosome Pattern
F. Mitelman (1972)
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
B. Mintz (1975)
Human lymphoblastoid cell lines. II. Cytogenetic studies.
C. Steel (1971)
Mutation selection and the natural history of cancer
J. Cairns (1975)
Cellular membranes and tumor behavior: a new hypothesis.
D. Wallach (1968)
Comparative frequency of dominant and recessive markers for drug resistance in Chinese hamster cells.
Michael H. Harris (1974)
Sequential cytogenetic changes in the evolution of transplanted thyroid tumors to metastatic carcinoma in the Fischer rat.
A. al-Saadi (1967)
A chromosomal theory of carcinogenesis.
J. Grouchy (1968)
Chromosome banding studies in acute leukaemia at diagnosis.
S. D. Lawler (1975)
Is there another approach to cancer therapy?--Workshop on suppression of the malignant phenotype.
P. Stansly (1975)
FURTHER STUDIES ON KARYOTYPES OF A VARIETY OF PRIMARY AND TRANSPLANTED MOUSE POLYOMA TUMORS.
K. Hellstroem (1963)
Unscheduled DNA synthesis, u.v.‐induced chromosome aberrations adn SV40 transformation in cultured cells from xeroderma pigmentosum
J. Parrington (1971)
Chromosomes of "minimal deviation" hepatomas and some other transplantable rat tumors.
P. Nowell (1967)
Methodology in mammalian genetics
W. J. Burdette (1962)
Carcinogens, enzyme induction, and gene action.
H. Gelboin (1967)
CHROMOSOME STUDIES OF VIRUS-INDUCED RABBIT PAPILLOMAS AND DERIVED PRIMARY CARCINOMAS.
H. Mcmichael (1963)
Mechanism of cell transformation by RNA tumor viruses.
H. Temin (1971)
Clustering of aberrations to specific chromosomes in human neoplasms.
G. Levan (1975)
Regression and persistence of hyperplastic hepatic nodules induced by N-2-Fluorenylacetamide and their relationship to hepatocarcinogenesis.
G. Teebor (1971)
Cancer, differentiation and embryonic antigens: some central problems.
J. Coggin (1974)
The origin and development of human tumors studied with cell markers.
P. J. Fialkow (1974)
Chromosomes and causation of human cancer and leukemia. II. Karyotypes of human solid tumors
K. Yamada (1966)
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
D. Linder (1965)
Viral “Tumorigenesis” in man: Cell markers in condylomata acuminata
J. Friedman (1976)
Nonrandom chromosomal abnormalities in hematologic disorders of man.
J. Rowley (1975)
Assignment of the T-antigen gene of simian virus 40 to human chromosome C-7.
C. Croce (1973)
Studies on the Variability of Immunoglobulin Sequence
C. Milstein (1967)
Carcinogenesis--cellular evolution as a unifying thread: Presidential address.
E. Farber (1973)
Chromosome aberrations in cultured cells deprived of single essential amino acids.
J. Freed (1969)
Chromosomal abnormalities in human neoplasia.
A. Sandberg (1970)
Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. I. Banding analyses of isoantigenic variant sublines derived from the fusion of TA3Ha carcinoma with MSWBS sarcoma cells.
F. Wiener (1974)
Differentiation of malignant to benign cells.
G. B. Pierce (1971)
ROLE OF CHROMOSOMES IN CANCEROGENESIS, AS STUDIED IN SERIAL TISSUE CULTURE OF MAMMALIAN CELLS
A. Levan (1958)
The analysis of malignancy by cell fusion. IV. Hybrid between tumour cells and a malignant L cell derivative.
F. Wiener (1973)
Radiation carcinogenesis: the sequence of events.
L. Cole (1965)
This paper is referenced by
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
S. Dentro (2020)
Clonal Analysis of Normal and Malignant Human Hematopoietic Hierarchies
F. Notta (2012)
The metabolic state of cancer stem cells-a valid target for cancer therapy?
E. Vlashi (2015)
Effect Sizes of Somatic Mutations in Cancer
Vincent L. Cannataro (2018)
Acquiring Metastatic Competence by Oral Squamous Cell Carcinoma Cells Is Associated with Differential Expression of α-Tubulin Isoforms
B. Lou (2012)
Links between DNA Replication, Stem Cells and Cancer
A. Vassilev (2017)
Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas
Anna De Grassi (2014)
New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management.
B. Reid (2011)
Biomarkers to Target Heterogeneous Breast Cancer Stem Cells
W. Hwang-Verslues (2012)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham (2013)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
T. Rausch (2012)
Is Co-option a prevailing mechanism during cancer progression?
M. Billaud (2011)
Cancer stem cells in tumor heterogeneity.
A. Pietras (2011)
Cancer stem cells: a new framework for the design of tumor therapies
B. Garvalov (2010)
Detecting recurrent gene mutation in interaction network context using multi-scale graph diffusion
Sepideh Babaei (2012)
Hypothesis on the role of cytoplasmic "short base sequences" in carcinogenesis.
Jing-yao Zhang (2013)
Forward and reverse mutations in stages of cancer development
Taobo Hu (2018)
The dualistic origin of human tumors
J. Liu (2018)
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
S. Yi (2017)
Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis
M. Gausachs (2017)
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
Klara M. Giessler (2017)
Advances in understanding tumour evolution through single-cell sequencing*
Jack Kuipers (2017)
The Physics of Cancer
C. L. Porta (2017)
Homeostasis Back and Forth: An Eco-Evolutionary Perspective of Cancer
D. Basanta (2016)
Role of EGCG in Containing the Progression of Lung Tumorigenesis – A Multistage Targeting Approach
S. Dhatwalia (2018)
Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
C. Douville (2018)
Texture analysis of high-resolution dedicated breast 18F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer
A. Moscoso (2017)
Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance.
D. Fitzgerald (2017)
Prominent features of the amino acid mutation landscape in cancer
Zachary A. Szpiech (2017)
Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
F. Schmidt (2016)
Why is cancer not more common? A changing microenvironment may help to explain why, and suggests strategies for anti-cancer therapy
Xiaowei Jiang (2019)
The Detection of Dynamical Organization in Cancer Evolution Models
L. Sani (2019)See more